Traditional Chinese medicine monomer composition for preparation of drugs used for treating polycystic ovarian syndrome and preparation method thereof

A technology of monomer composition and polycystic ovary, which is applied in the preparation of traditional Chinese medicine monomer composition for treating polycystic ovary syndrome. No side effects and other problems, to achieve the effect of small side effects, low toxicity, and promote follicle maturation
CN103285022AActive Publication Date: 2013-09-11SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
1 Cites 9 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Publication Date
2013-09-11

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a traditional Chinese medicine monomer composition for preparation of drugs used for treating polycystic ovarian syndrome. The invention is characterized in that the traditional Chinese medicine monomer composition comprises, by mass, 2 to 4% of cryptotanshinone, 13 to 18% of baicalin, 7 to 10% of quercetin and 65 to 80% of adjuvants, wherein the percentages of the above-mentioned components sum to 100%. According to results of in vivo experiments, combined application of the three traditional Chinese medicine monomers consisting of cryptotanshinone, baicalin and quercetin exerts an obvious therapeutic effect on the polycystic ovarian syndrome of a rat model and can substantially increase the level of androgen, promote maturation of ovarian follicles and induce ovulation. More importantly, the three traditional Chinese medicine monomers have no toxicity to the liver and the kidney, little side effects and incomparable security. Thus, the traditional Chinese medicine monomer composition provided by the invention can be used for preparing the drugs used for treating the polycystic ovarian syndrome and has good prospects.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of pharmacy, and relates to a traditional Chinese medicine monomer composition for treating polycystic ovary syndrome; in addition, the invention also relates to a preparation method and a medical application of the traditional Chinese medicine monomer composition. Background technique

[0002] Cryptotanshinone (Cryptotanshinone) is a fat-soluble diterpenoid extracted from the dry root and rhizome of the plant Salvia miltiorrhiza in the Labiatae family. Its molecular formula is C 19 h 20 o 3 , molecular weight: 296.35, structural formula:

[0003]

[0004] Modern pharmacological studies have shown that cryptotanshinone has antibacterial, anti-oxidant, and anti-aging functions, and has certain curative effects on the treatment of coronary heart disease, angina pectoris, and myocardial damage. Another study shows that cryptotanshinone can inhibit the expression of androgen, and can be used to treat diseases relate...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More